looking bad, collapse underway?
Not much to hang your hopes on here, it looks like a double top with the second top being a head and shoulders. The divergence between RSI and price at the two tops is tenuous, but I wish it wasn't even possible to consider it. As far as the financial statement is concerned, it says the IPO was in 2015 and I guess it's standard procedure for biotechs to lose money for some years but you'd think that a solid company would wait to go public until they were nearly profitable, wouldn't you? Anyway, I'm down 26% from where I bought in, that's the limit for me really and I'd have bailed today except for the small rise... Thanks for any perspective!
註釋
Wow, it really nose-dived soon after that post.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。